Skip to content

AbbVie 3D regimen cures most genotype 1 HCV in people with HIV and HCV co-infection

Mark Sulkowski, from Johns Hopkins University School of Medicine, speaking at AIDS 2014. Photo: International AIDS Society/Steve Forrest.

Sofosbuvir + ribavirin cures hepatitis C for more than 80% of people with HIV and HCV co-infection

Jean-Michel Molina presents the results of PHOTON-2. Photo by Liz Highleyman, hivandhepatitis.com

Recession and income inequality have fuelled HIV infections in European drug users

Georgios Nikolopoulos, of the University of Athens, presenting at AIDS 2014. Image by Roger Pebody (aidsmap.com).

AIDS 2014 opening ceremony honours Flight MH17 dead with drive to end AIDS by 2030

Activists call for '100% undetectable by 2020' target on the opening day of AIDS 2014. Professor Joep Lange appears on screen. Photo by Liz Highleyman, hivandhepatitis.com

European CDC cautious about PrEP

Protease inhibitor therapy doesn't reduce the risk of malaria for HIV-positive pregnant women

Study finds no evidence that HIV-positive gay men in UK have increased risk of neurocognitive impairment

High levels of adherence to study medication among women who conceived during HIV PrEP study

High rates of drug resistance among HIV-positive infants in South Africa